FENC Financials
Fennec Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$12.31
Market Cap
$302.21M
P/E Ratio
-615.8
EPS
$-0.26
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$47.54M
Gross Profit
-
Operating Income
-
Net Income
$-436,000
EPS (Diluted)
$-0.02
Balance Sheet Highlights
Total Assets
$44.95M
Total Liabilities
$50.82M
Shareholders Equity
-
Cash & Equivalents
$26.63M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$26.98M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-1.5%
Net Margin
-17.9%
ROE
-1005.6%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is FENC revenue?
FENC's most recent quarterly revenue was $47.54M. Annual revenue can be calculated by summing the four most recent quarters.
Is FENC profitable?
FENC reported a loss of $436,000 in the most recent quarter. The net profit margin is -17.9%.
What is FENC market cap?
FENC has a market capitalization of $302.21M, making it a small-cap stock.
Does FENC have debt?
View FENC's balance sheet for debt information.
What is FENC cash flow?
Cash flow data is available in the full financial statements.